Structural Bases for Stability-Function Tradeoffs in Antibiotic Resistance

被引:71
作者
Thomas, Veena L. [1 ,2 ]
McReynolds, Andrea C. [1 ]
Shoichet, Brian K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogenom, San Francisco, CA 94158 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
protein stability; AmpC beta-lactamase; antibiotic resistance; evolution; action at a distance; AMPC BETA-LACTAMASE; TRANSITION-STATE ANALOG; PROTEIN STABILITY; CATALYTIC MECHANISM; SERRATIA-MARCESCENS; DIRECTED EVOLUTION; SITE; SUBSTRATE; INHIBITOR; BINDING;
D O I
10.1016/j.jmb.2009.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Preorganization of enzyme active sites for substrate recognition typically comes at a cost to the stability of the folded form of the protein; consequently, enzymes can be dramatically stabilized by substitutions that attenuate the size and preorganization "strain" of the active site. How this stability-activity tradeoff constrains enzyme evolution has remained less certain, and it is unclear whether one should expect major stability insults as enzymes mutate towards new activities or how these new activities manifest structurally. These questions are both germane and easy to study in beta-lactamases, which are evolving on the timescale of years to confer resistance to an ever-broader spectrum of beta-lactam antibiotics. To explore whether stability is a substantial constraint on this antibiotic resistance evolution, we investigated extended-spectrum mutants of class C beta-lactamases, which had evolved new activity versus third-generation cephalosporins. Five mutant enzymes had between 100-fold and 200-fold increased activity against the antibiotic cefotaxime in enzyme assays, and the mutant enzymes all lost thermodynamic stability (from 1.7 kcal mol(-1) to 4.1 kcal mol(-1)), consistent with the stability-function hypothesis. Intriguingly, several of the substitutions were 10-20 angstrom from the catalytic serine; the question of how they conferred extended-spectrum activity arose. Eight structures, including complexes with inhibitors and extended-spectrum antibiotics, were determined by X-ray crystallography. Distinct mechanisms of action, including changes in the flexibility and ground-state structures of the enzyme, are revealed for each mutant. These results explain the structural bases for the antibiotic resistance conferred by these substitutions and their corresponding decrease in protein stability, which will constrain the evolution of new antibiotic resistance. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:47 / 59
页数:13
相关论文
共 61 条
[41]  
Powers RA, 1999, PROTEIN SCI, V8, P2330
[42]   Structures of ceftazidime and its transition-state analogue in complex with AmpC β-lactamase:: Implications for resistance mutations and inhibitor design [J].
Powers, RA ;
Caselli, E ;
Focia, PJ ;
Prati, F ;
Shoichet, BK .
BIOCHEMISTRY, 2001, 40 (31) :9207-9214
[43]   Mutation in Serratia marcescens AmpC β-lactamase producing high-level resistance to ceftazidime and cefpirome [J].
Raimondi, A ;
Sisto, F ;
Nikaido, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2331-2339
[44]   INTERPRETATION OF PROTEIN STRUCTURES - TOTAL VOLUME, GROUP VOLUME DISTRIBUTIONS AND PACKING DENSITY [J].
RICHARDS, FM .
JOURNAL OF MOLECULAR BIOLOGY, 1974, 82 (01) :1-14
[45]   Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials - Compensatory modulations of binding and activity [J].
Schock, HB ;
Garsky, VM ;
Kuo, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) :31957-31963
[46]   STABILITY AND FUNCTION - 2 CONSTRAINTS IN THE EVOLUTION OF BARSTAR AND OTHER PROTEINS [J].
SCHREIBER, C ;
BUCKLE, AM ;
FERSHT, AR .
STRUCTURE, 1994, 2 (10) :945-951
[47]   Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia [J].
Shah, NP ;
Nicoll, JM ;
Nagar, B ;
Gorre, ME ;
Paquette, RL ;
Kuriyan, J ;
Sawyers, CL .
CANCER CELL, 2002, 2 (02) :117-125
[48]   A RELATIONSHIP BETWEEN PROTEIN STABILITY AND PROTEIN FUNCTION [J].
SHOICHET, BK ;
BAASE, WA ;
KUROKI, R ;
MATTHEWS, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (02) :452-456
[49]   A secondary drug resistance mutation of TEM-1 β-lactamase that suppresses misfolding and aggregation [J].
Sideraki, V ;
Huang, WZ ;
Palzkill, T ;
Gilbert, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :283-288
[50]   Chaperonin overexpression promotes genetic variation and enzyme evolution [J].
Tokuriki, Nobuhiko ;
Tawfik, Dan S. .
NATURE, 2009, 459 (7247) :668-U71